Apeiron Research Center

Apeiron Research Center conducts translational biomedical research focused on autologous cellular and biologic therapies, including bone marrowderived, adipose-derived, and platelet-based products. Program activities include laboratory characterization of biologic materials, development and validation of standardized processing methods, preclinical safety studies, and ethically supervised clinical research evaluating safety and biologic function. A central program objective is the structured advancement of research findings toward regulatory-compliant autologous Good Manufacturing Practice (GMP) processes that may support future clinical trials and evidence-based therapeutic applications. The organization maintains comprehensive quality management systems to ensure reproducibility, patient protection, and alignment with applicable federal and state regulatory standards. Research results contribute to scientific knowledge.

The Boulder Biologics Research Center is organized exclusively for scientific and educational purposes, including conducting and supporting research in regenerative medicineand cellular therapies to advance public health, develop safe and effective biologic treatments, and disseminate findings through education and collaboration within the scientific community.